MedPath

Steroid injections or Rebamipide tablets, which is better to treat painful and difficult mouth opening (OSMF)

Phase 4
Conditions
Health Condition 1: K135- Oral submucous fibrosis
Registration Number
CTRI/2022/12/048127
Lead Sponsor
Osmania Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with OSMF with stomatopyrosis and/or grade 1 or 2 trismus

Patients willing to take intralesional Triamcinolone + Hyaluronidase

Patients willing to take oral Rebamipide tablets

Patients willing to abstain from smoking/betel nut chewing (if addicted)

Exclusion Criteria

Patients not willing for follow up

Patients with diagnosed oral malignancy

Patients with grade 3 trismus or above

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of trismus to grade 1 or 0 <br/ ><br>Resolution of stomatopyrosisTimepoint: 4 weeks after starting intervention
Secondary Outcome Measures
NameTimeMethod
Increased patient compliance to treatmentTimepoint: 28 days
© Copyright 2025. All Rights Reserved by MedPath